These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 17597457)

  • 21. Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation.
    Panigrahi R; Hazari S; Chandra S; Chandra PK; Datta S; Kurt R; Cameron CE; Huang Z; Zhang H; Garry RF; Balart LA; Dash S
    PLoS One; 2013; 8(8):e72791. PubMed ID: 24009705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cells inhibit hepatitis C virus expression.
    Li Y; Zhang T; Ho C; Orange JS; Douglas SD; Ho WZ
    J Leukoc Biol; 2004 Dec; 76(6):1171-9. PubMed ID: 15339939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different anti-HCV profiles of statins and their potential for combination therapy with interferon.
    Ikeda M; Abe K; Yamada M; Dansako H; Naka K; Kato N
    Hepatology; 2006 Jul; 44(1):117-25. PubMed ID: 16799963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.
    Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ
    Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin.
    Zhao LJ; Wang W; Liu Y; Ren H; Qi ZT
    Antiviral Res; 2012 Nov; 96(2):260-8. PubMed ID: 22985631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxyurea as an inhibitor of hepatitis C virus RNA replication.
    Nozaki A; Morimoto M; Kondo M; Oshima T; Numata K; Fujisawa S; Kaneko T; Miyajima E; Morita S; Mori K; Ikeda M; Kato N; Tanaka K
    Arch Virol; 2010 Apr; 155(4):601-5. PubMed ID: 20204428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translational insensitivity to potent activation of PKR by HCV IRES RNA.
    Shimoike T; McKenna SA; Lindhout DA; Puglisi JD
    Antiviral Res; 2009 Sep; 83(3):228-37. PubMed ID: 19467267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alcohol potentiates hepatitis C virus replicon expression.
    Zhang T; Li Y; Lai JP; Douglas SD; Metzger DS; O'Brien CP; Ho WZ
    Hepatology; 2003 Jul; 38(1):57-65. PubMed ID: 12829987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
    Itsui Y; Sakamoto N; Kurosaki M; Kanazawa N; Tanabe Y; Koyama T; Takeda Y; Nakagawa M; Kakinuma S; Sekine Y; Maekawa S; Enomoto N; Watanabe M
    J Viral Hepat; 2006 Oct; 13(10):690-700. PubMed ID: 16970601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of finding synergic in vitro drug-drug interactions between interferon-alpha and ribavirin for the treatment of hepatitis C virus.
    Buckwold VE
    J Antimicrob Chemother; 2004 Mar; 53(3):413-4. PubMed ID: 14963071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of bovine viral diarrhea virus in vitro by xanthohumol: comparisons with ribavirin and interferon-alpha and implications for the development of anti-hepatitis C virus agents.
    Zhang N; Liu Z; Han Q; Chen J; Lou S; Qiu J; Zhang G
    Eur J Pharm Sci; 2009 Nov; 38(4):332-40. PubMed ID: 19720145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.
    Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M
    J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ribavirin inhibits DNA, RNA, and protein synthesis in PHA-stimulated human peripheral blood mononuclear cells: possible explanation for therapeutic efficacy in patients with chronic HCV infection.
    Meier V; Bürger E; Mihm S; Saile B; Ramadori G
    J Med Virol; 2003 Jan; 69(1):50-8. PubMed ID: 12436477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-HCV activities of selective polyunsaturated fatty acids.
    Leu GZ; Lin TY; Hsu JT
    Biochem Biophys Res Commun; 2004 May; 318(1):275-80. PubMed ID: 15110784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy.
    Hofmann WP; Zeuzem S; Sarrazin C
    J Clin Virol; 2005 Feb; 32(2):86-91. PubMed ID: 15653410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism.
    Diamond MS; Harris E
    Virology; 2001 Oct; 289(2):297-311. PubMed ID: 11689052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication.
    Li Y; Ye L; Peng JS; Wang CQ; Luo GX; Zhang T; Wan Q; Ho WZ
    J Infect Dis; 2007 Sep; 196(5):719-30. PubMed ID: 17674315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha.
    Toma S; Yamashiro T; Arakaki S; Shiroma J; Maeshiro T; Hibiya K; Sakamoto N; Kinjo F; Tateyama M; Fujita J
    J Viral Hepat; 2009 Jul; 16(7):506-12. PubMed ID: 19302339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping of the interacting domains of hepatitis C virus core protein and the double-stranded RNA-activated protein kinase PKR.
    Yan XB; Battaglia S; Boucreux D; Chen Z; Brechot C; Pavio N
    Virus Res; 2007 Apr; 125(1):79-87. PubMed ID: 17267064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.